The Application of Cyclo-Oxygenase Inhibitor after Cataract Surgery.

马晓昀,邹俊,吴强,俞嘉怡,朱捷,陈国辉,杨冠
DOI: https://doi.org/10.3760/cma.j.issn.2095-1477.2003.07.027
2003-01-01
Abstract:Objective To evaluate the efficacy and safety of cyclo-oxgenase inhibitor(Pranoprofen 0.1% eye drops) for postoperative inflammation after phacoemulsification and posterior chamber intraocular lens (IOL) implantation.Methods 60 patients(60 eyes) were randomly distributed into three medication groups with 20 patienes (20 eyes) each. A group was treated with Tobradex eyedrops for 7 days and Pranoprofen eyedrops for another 7 days. B group was treated with Tobradex eyedrops for 14 days. C group was treated with Pranoprofen eyedrops for 14 days. All eye-drops were administered 4 times each day starting from the first day after cataract surgery. The symptoms and signs, visual acuity and intraocular pressure(IOP) changes were examined and compared at ld,7d,and 14d postoperatively. Results Post-operative symptoms and signs at each stage were obviously improved in the three groups, in which the scores were statistically different (P 0.05) .Compared with A and B group at postoperative 7d and 14d, the score of the C group was significatly differ-ent( P 0.05) . There was no difference of IOP changes of the three groups at each stage( P 0.05) . However, B group has the tendency of ascending IOP at 14d postiperatively. Conclusion Tobradex eyedrops combined with Pranoprofen eyedrops may be more effectively and safety used to control inflammation after cataract surgery.
What problem does this paper attempt to address?